nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—HDAC2—Lovastatin—atherosclerosis	0.659	0.871	CbGbCtD
Aminophylline—CYP3A4—Rosuvastatin—atherosclerosis	0.0205	0.0271	CbGbCtD
Aminophylline—CYP3A4—Ezetimibe—atherosclerosis	0.0205	0.0271	CbGbCtD
Aminophylline—CYP3A4—Simvastatin—atherosclerosis	0.0191	0.0252	CbGbCtD
Aminophylline—CYP3A4—Lovastatin—atherosclerosis	0.0187	0.0247	CbGbCtD
Aminophylline—CYP3A4—Pravastatin—atherosclerosis	0.0187	0.0247	CbGbCtD
Aminophylline—PDE3A—penis—atherosclerosis	0.00574	0.323	CbGeAlD
Aminophylline—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00246	0.0231	CcSEcCtD
Aminophylline—Peptic ulcer—Niacin—atherosclerosis	0.00237	0.0223	CcSEcCtD
Aminophylline—Heartburn—Niacin—atherosclerosis	0.0023	0.0217	CcSEcCtD
Aminophylline—Heartburn—Pravastatin—atherosclerosis	0.00227	0.0213	CcSEcCtD
Aminophylline—Rhabdomyolysis—Lovastatin—atherosclerosis	0.00209	0.0196	CcSEcCtD
Aminophylline—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.00205	0.0192	CcSEcCtD
Aminophylline—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.002	0.0188	CcSEcCtD
Aminophylline—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00195	0.0183	CcSEcCtD
Aminophylline—Rhabdomyolysis—Niacin—atherosclerosis	0.00179	0.0168	CcSEcCtD
Aminophylline—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00176	0.0166	CcSEcCtD
Aminophylline—Hyperuricaemia—Niacin—atherosclerosis	0.00171	0.0161	CcSEcCtD
Aminophylline—Blood uric acid increased—Niacin—atherosclerosis	0.00161	0.0152	CcSEcCtD
Aminophylline—Dermatitis contact—Niacin—atherosclerosis	0.00157	0.0147	CcSEcCtD
Aminophylline—HDAC2—Lovastatin—Pravastatin—atherosclerosis	0.00152	0.222	CbGdCrCtD
Aminophylline—HDAC2—Lovastatin—Simvastatin—atherosclerosis	0.00152	0.222	CbGdCrCtD
Aminophylline—Skin exfoliation—Niacin—atherosclerosis	0.00151	0.0142	CcSEcCtD
Aminophylline—Atrial fibrillation—Simvastatin—atherosclerosis	0.00132	0.0124	CcSEcCtD
Aminophylline—Polyuria—Niacin—atherosclerosis	0.00131	0.0123	CcSEcCtD
Aminophylline—HDAC2—Fluvastatin—Rosuvastatin—atherosclerosis	0.0013	0.191	CbGdCrCtD
Aminophylline—HDAC2—Simvastatin—Pravastatin—atherosclerosis	0.00124	0.182	CbGdCrCtD
Aminophylline—HDAC2—Simvastatin—Lovastatin—atherosclerosis	0.00124	0.182	CbGdCrCtD
Aminophylline—Atrial fibrillation—Niacin—atherosclerosis	0.00121	0.0114	CcSEcCtD
Aminophylline—Haematuria—Rosuvastatin—atherosclerosis	0.00116	0.0109	CcSEcCtD
Aminophylline—ADORA2B—adipose tissue—atherosclerosis	0.0011	0.0621	CbGeAlD
Aminophylline—Urinary retention—Niacin—atherosclerosis	0.00109	0.0103	CcSEcCtD
Aminophylline—ADORA2A—cardiovascular system—atherosclerosis	0.00104	0.0586	CbGeAlD
Aminophylline—HDAC2—connective tissue—atherosclerosis	0.00102	0.0574	CbGeAlD
Aminophylline—PDE4A—adipose tissue—atherosclerosis	0.000984	0.0553	CbGeAlD
Aminophylline—Arrhythmia—Rosuvastatin—atherosclerosis	0.000977	0.00919	CcSEcCtD
Aminophylline—PDE3A—cardiovascular system—atherosclerosis	0.000923	0.0519	CbGeAlD
Aminophylline—ADORA1—cardiovascular system—atherosclerosis	0.0009	0.0506	CbGeAlD
Aminophylline—HDAC2—cardiovascular system—atherosclerosis	0.000889	0.0499	CbGeAlD
Aminophylline—Flushing—Lovastatin—atherosclerosis	0.00086	0.00809	CcSEcCtD
Aminophylline—Flushing—Ezetimibe—atherosclerosis	0.000844	0.00793	CcSEcCtD
Aminophylline—Alopecia—Lovastatin—atherosclerosis	0.000819	0.0077	CcSEcCtD
Aminophylline—PDE3A—adipose tissue—atherosclerosis	0.000814	0.0458	CbGeAlD
Aminophylline—Flushing—Simvastatin—atherosclerosis	0.000805	0.00757	CcSEcCtD
Aminophylline—Alopecia—Ezetimibe—atherosclerosis	0.000804	0.00755	CcSEcCtD
Aminophylline—ADORA1—adipose tissue—atherosclerosis	0.000793	0.0446	CbGeAlD
Aminophylline—HDAC2—adipose tissue—atherosclerosis	0.000784	0.044	CbGeAlD
Aminophylline—Infection—Rosuvastatin—atherosclerosis	0.000772	0.00726	CcSEcCtD
Aminophylline—Alopecia—Simvastatin—atherosclerosis	0.000766	0.0072	CcSEcCtD
Aminophylline—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000762	0.00716	CcSEcCtD
Aminophylline—Tremor—Lovastatin—atherosclerosis	0.000756	0.00711	CcSEcCtD
Aminophylline—Flushing—Niacin—atherosclerosis	0.000739	0.00695	CcSEcCtD
Aminophylline—Flushing—Pravastatin—atherosclerosis	0.000728	0.00684	CcSEcCtD
Aminophylline—Arrhythmia—Niacin—atherosclerosis	0.000711	0.00669	CcSEcCtD
Aminophylline—Tremor—Simvastatin—atherosclerosis	0.000707	0.00665	CcSEcCtD
Aminophylline—Alopecia—Niacin—atherosclerosis	0.000704	0.00661	CcSEcCtD
Aminophylline—Insomnia—Rosuvastatin—atherosclerosis	0.000703	0.00661	CcSEcCtD
Aminophylline—Arrhythmia—Pravastatin—atherosclerosis	0.0007	0.00658	CcSEcCtD
Aminophylline—Palpitations—Ezetimibe—atherosclerosis	0.0007	0.00658	CcSEcCtD
Aminophylline—Alopecia—Pravastatin—atherosclerosis	0.000693	0.00651	CcSEcCtD
Aminophylline—Anxiety—Lovastatin—atherosclerosis	0.000685	0.00644	CcSEcCtD
Aminophylline—Dyspepsia—Rosuvastatin—atherosclerosis	0.000684	0.00643	CcSEcCtD
Aminophylline—Tension—Niacin—atherosclerosis	0.00068	0.00639	CcSEcCtD
Aminophylline—Nervousness—Niacin—atherosclerosis	0.000673	0.00633	CcSEcCtD
Aminophylline—Tension—Pravastatin—atherosclerosis	0.00067	0.0063	CcSEcCtD
Aminophylline—Nervousness—Pravastatin—atherosclerosis	0.000663	0.00623	CcSEcCtD
Aminophylline—Anaphylactic shock—Lovastatin—atherosclerosis	0.000659	0.00619	CcSEcCtD
Aminophylline—Infection—Lovastatin—atherosclerosis	0.000654	0.00615	CcSEcCtD
Aminophylline—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000646	0.00607	CcSEcCtD
Aminophylline—ADORA2A—liver—atherosclerosis	0.000644	0.0362	CbGeAlD
Aminophylline—Infection—Ezetimibe—atherosclerosis	0.000642	0.00603	CcSEcCtD
Aminophylline—Anxiety—Simvastatin—atherosclerosis	0.00064	0.00602	CcSEcCtD
Aminophylline—Tremor—Pravastatin—atherosclerosis	0.000639	0.00601	CcSEcCtD
Aminophylline—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000636	0.00597	CcSEcCtD
Aminophylline—Nervous system disorder—Ezetimibe—atherosclerosis	0.000634	0.00596	CcSEcCtD
Aminophylline—Anorexia—Lovastatin—atherosclerosis	0.000628	0.0059	CcSEcCtD
Aminophylline—Urticaria—Rosuvastatin—atherosclerosis	0.000617	0.0058	CcSEcCtD
Aminophylline—Anaphylactic shock—Simvastatin—atherosclerosis	0.000616	0.00579	CcSEcCtD
Aminophylline—Abdominal pain—Rosuvastatin—atherosclerosis	0.000614	0.00578	CcSEcCtD
Aminophylline—Palpitations—Niacin—atherosclerosis	0.000613	0.00576	CcSEcCtD
Aminophylline—Infection—Simvastatin—atherosclerosis	0.000612	0.00575	CcSEcCtD
Aminophylline—Insomnia—Lovastatin—atherosclerosis	0.000596	0.0056	CcSEcCtD
Aminophylline—Anorexia—Simvastatin—atherosclerosis	0.000587	0.00552	CcSEcCtD
Aminophylline—Insomnia—Ezetimibe—atherosclerosis	0.000584	0.00549	CcSEcCtD
Aminophylline—Dyspepsia—Lovastatin—atherosclerosis	0.00058	0.00545	CcSEcCtD
Aminophylline—Anxiety—Pravastatin—atherosclerosis	0.000579	0.00544	CcSEcCtD
Aminophylline—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000573	0.00538	CcSEcCtD
Aminophylline—Decreased appetite—Lovastatin—atherosclerosis	0.000573	0.00538	CcSEcCtD
Aminophylline—PDE3A—liver—atherosclerosis	0.000571	0.0321	CbGeAlD
Aminophylline—Dyspepsia—Ezetimibe—atherosclerosis	0.000569	0.00535	CcSEcCtD
Aminophylline—Anaphylactic shock—Niacin—atherosclerosis	0.000566	0.00532	CcSEcCtD
Aminophylline—Decreased appetite—Ezetimibe—atherosclerosis	0.000562	0.00528	CcSEcCtD
Aminophylline—Insomnia—Simvastatin—atherosclerosis	0.000557	0.00524	CcSEcCtD
Aminophylline—Anaphylactic shock—Pravastatin—atherosclerosis	0.000557	0.00524	CcSEcCtD
Aminophylline—Shock—Niacin—atherosclerosis	0.000557	0.00523	CcSEcCtD
Aminophylline—Infection—Pravastatin—atherosclerosis	0.000553	0.0052	CcSEcCtD
Aminophylline—Tachycardia—Niacin—atherosclerosis	0.000552	0.00519	CcSEcCtD
Aminophylline—Pruritus—Rosuvastatin—atherosclerosis	0.00055	0.00517	CcSEcCtD
Aminophylline—HDAC2—liver—atherosclerosis	0.00055	0.0309	CbGeAlD
Aminophylline—Dyspepsia—Simvastatin—atherosclerosis	0.000542	0.0051	CcSEcCtD
Aminophylline—Anorexia—Niacin—atherosclerosis	0.000539	0.00507	CcSEcCtD
Aminophylline—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000539	0.00506	CcSEcCtD
Aminophylline—Decreased appetite—Simvastatin—atherosclerosis	0.000536	0.00503	CcSEcCtD
Aminophylline—Diarrhoea—Rosuvastatin—atherosclerosis	0.000532	0.005	CcSEcCtD
Aminophylline—Anorexia—Pravastatin—atherosclerosis	0.000531	0.00499	CcSEcCtD
Aminophylline—Hypotension—Niacin—atherosclerosis	0.000529	0.00497	CcSEcCtD
Aminophylline—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000528	0.00497	CcSEcCtD
Aminophylline—Urticaria—Lovastatin—atherosclerosis	0.000523	0.00492	CcSEcCtD
Aminophylline—Abdominal pain—Lovastatin—atherosclerosis	0.000521	0.00489	CcSEcCtD
Aminophylline—Body temperature increased—Lovastatin—atherosclerosis	0.000521	0.00489	CcSEcCtD
Aminophylline—Dizziness—Rosuvastatin—atherosclerosis	0.000514	0.00483	CcSEcCtD
Aminophylline—Urticaria—Ezetimibe—atherosclerosis	0.000513	0.00482	CcSEcCtD
Aminophylline—Insomnia—Niacin—atherosclerosis	0.000512	0.00481	CcSEcCtD
Aminophylline—Abdominal pain—Ezetimibe—atherosclerosis	0.000511	0.0048	CcSEcCtD
Aminophylline—Body temperature increased—Ezetimibe—atherosclerosis	0.000511	0.0048	CcSEcCtD
Aminophylline—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000504	0.00474	CcSEcCtD
Aminophylline—Insomnia—Pravastatin—atherosclerosis	0.000504	0.00474	CcSEcCtD
Aminophylline—Dyspepsia—Niacin—atherosclerosis	0.000498	0.00468	CcSEcCtD
Aminophylline—Decreased appetite—Niacin—atherosclerosis	0.000492	0.00462	CcSEcCtD
Aminophylline—Dyspepsia—Pravastatin—atherosclerosis	0.00049	0.00461	CcSEcCtD
Aminophylline—Rash—Rosuvastatin—atherosclerosis	0.00049	0.00461	CcSEcCtD
Aminophylline—Dermatitis—Rosuvastatin—atherosclerosis	0.00049	0.0046	CcSEcCtD
Aminophylline—Urticaria—Simvastatin—atherosclerosis	0.000489	0.0046	CcSEcCtD
Aminophylline—Body temperature increased—Simvastatin—atherosclerosis	0.000487	0.00458	CcSEcCtD
Aminophylline—Abdominal pain—Simvastatin—atherosclerosis	0.000487	0.00458	CcSEcCtD
Aminophylline—Headache—Rosuvastatin—atherosclerosis	0.000487	0.00458	CcSEcCtD
Aminophylline—Hypersensitivity—Lovastatin—atherosclerosis	0.000485	0.00456	CcSEcCtD
Aminophylline—Decreased appetite—Pravastatin—atherosclerosis	0.000484	0.00455	CcSEcCtD
Aminophylline—Hypersensitivity—Ezetimibe—atherosclerosis	0.000476	0.00447	CcSEcCtD
Aminophylline—Pruritus—Lovastatin—atherosclerosis	0.000466	0.00438	CcSEcCtD
Aminophylline—Gastrointestinal pain—Niacin—atherosclerosis	0.000463	0.00435	CcSEcCtD
Aminophylline—Nausea—Rosuvastatin—atherosclerosis	0.000462	0.00434	CcSEcCtD
Aminophylline—Pruritus—Ezetimibe—atherosclerosis	0.000457	0.0043	CcSEcCtD
Aminophylline—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000455	0.00428	CcSEcCtD
Aminophylline—Hypersensitivity—Simvastatin—atherosclerosis	0.000454	0.00427	CcSEcCtD
Aminophylline—Diarrhoea—Lovastatin—atherosclerosis	0.000451	0.00424	CcSEcCtD
Aminophylline—Urticaria—Niacin—atherosclerosis	0.000449	0.00422	CcSEcCtD
Aminophylline—Body temperature increased—Niacin—atherosclerosis	0.000447	0.0042	CcSEcCtD
Aminophylline—Abdominal pain—Niacin—atherosclerosis	0.000447	0.0042	CcSEcCtD
Aminophylline—Urticaria—Pravastatin—atherosclerosis	0.000443	0.00416	CcSEcCtD
Aminophylline—Diarrhoea—Ezetimibe—atherosclerosis	0.000442	0.00415	CcSEcCtD
Aminophylline—Abdominal pain—Pravastatin—atherosclerosis	0.00044	0.00414	CcSEcCtD
Aminophylline—Body temperature increased—Pravastatin—atherosclerosis	0.00044	0.00414	CcSEcCtD
Aminophylline—Pruritus—Simvastatin—atherosclerosis	0.000436	0.0041	CcSEcCtD
Aminophylline—Dizziness—Lovastatin—atherosclerosis	0.000436	0.00409	CcSEcCtD
Aminophylline—Dizziness—Ezetimibe—atherosclerosis	0.000427	0.00402	CcSEcCtD
Aminophylline—Diarrhoea—Simvastatin—atherosclerosis	0.000422	0.00396	CcSEcCtD
Aminophylline—Vomiting—Lovastatin—atherosclerosis	0.000419	0.00394	CcSEcCtD
Aminophylline—Hypersensitivity—Niacin—atherosclerosis	0.000417	0.00392	CcSEcCtD
Aminophylline—Rash—Lovastatin—atherosclerosis	0.000415	0.0039	CcSEcCtD
Aminophylline—Dermatitis—Lovastatin—atherosclerosis	0.000415	0.0039	CcSEcCtD
Aminophylline—Headache—Lovastatin—atherosclerosis	0.000413	0.00388	CcSEcCtD
Aminophylline—Vomiting—Ezetimibe—atherosclerosis	0.000411	0.00386	CcSEcCtD
Aminophylline—Hypersensitivity—Pravastatin—atherosclerosis	0.00041	0.00386	CcSEcCtD
Aminophylline—Dizziness—Simvastatin—atherosclerosis	0.000407	0.00383	CcSEcCtD
Aminophylline—Rash—Ezetimibe—atherosclerosis	0.000407	0.00383	CcSEcCtD
Aminophylline—Dermatitis—Ezetimibe—atherosclerosis	0.000407	0.00383	CcSEcCtD
Aminophylline—Headache—Ezetimibe—atherosclerosis	0.000405	0.0038	CcSEcCtD
Aminophylline—Pruritus—Niacin—atherosclerosis	0.0004	0.00376	CcSEcCtD
Aminophylline—Pruritus—Pravastatin—atherosclerosis	0.000394	0.0037	CcSEcCtD
Aminophylline—Vomiting—Simvastatin—atherosclerosis	0.000392	0.00368	CcSEcCtD
Aminophylline—Nausea—Lovastatin—atherosclerosis	0.000391	0.00368	CcSEcCtD
Aminophylline—Rash—Simvastatin—atherosclerosis	0.000388	0.00365	CcSEcCtD
Aminophylline—Dermatitis—Simvastatin—atherosclerosis	0.000388	0.00365	CcSEcCtD
Aminophylline—Diarrhoea—Niacin—atherosclerosis	0.000387	0.00364	CcSEcCtD
Aminophylline—Headache—Simvastatin—atherosclerosis	0.000386	0.00363	CcSEcCtD
Aminophylline—Nausea—Ezetimibe—atherosclerosis	0.000384	0.00361	CcSEcCtD
Aminophylline—Diarrhoea—Pravastatin—atherosclerosis	0.000381	0.00358	CcSEcCtD
Aminophylline—Dizziness—Niacin—atherosclerosis	0.000374	0.00352	CcSEcCtD
Aminophylline—Dizziness—Pravastatin—atherosclerosis	0.000368	0.00346	CcSEcCtD
Aminophylline—CYP2E1—cardiovascular system—atherosclerosis	0.000368	0.0207	CbGeAlD
Aminophylline—Nausea—Simvastatin—atherosclerosis	0.000366	0.00344	CcSEcCtD
Aminophylline—Vomiting—Niacin—atherosclerosis	0.00036	0.00338	CcSEcCtD
Aminophylline—Rash—Niacin—atherosclerosis	0.000357	0.00335	CcSEcCtD
Aminophylline—Dermatitis—Niacin—atherosclerosis	0.000356	0.00335	CcSEcCtD
Aminophylline—Headache—Niacin—atherosclerosis	0.000354	0.00333	CcSEcCtD
Aminophylline—Vomiting—Pravastatin—atherosclerosis	0.000354	0.00333	CcSEcCtD
Aminophylline—Rash—Pravastatin—atherosclerosis	0.000351	0.0033	CcSEcCtD
Aminophylline—Dermatitis—Pravastatin—atherosclerosis	0.000351	0.0033	CcSEcCtD
Aminophylline—Headache—Pravastatin—atherosclerosis	0.000349	0.00328	CcSEcCtD
Aminophylline—Nausea—Niacin—atherosclerosis	0.000336	0.00316	CcSEcCtD
Aminophylline—Nausea—Pravastatin—atherosclerosis	0.000331	0.00311	CcSEcCtD
Aminophylline—CYP1A2—liver—atherosclerosis	0.000253	0.0142	CbGeAlD
Aminophylline—CYP2E1—liver—atherosclerosis	0.000227	0.0128	CbGeAlD
Aminophylline—CYP3A4—liver—atherosclerosis	0.000183	0.0103	CbGeAlD
Aminophylline—PDE3A—Signaling Pathways—IGF1—atherosclerosis	1.98e-05	0.000176	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—INS—atherosclerosis	1.98e-05	0.000175	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AGT—atherosclerosis	1.96e-05	0.000174	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—AKT1—atherosclerosis	1.95e-05	0.000173	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCL2—atherosclerosis	1.94e-05	0.000173	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NAMPT—atherosclerosis	1.94e-05	0.000172	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SERPINE1—atherosclerosis	1.94e-05	0.000172	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—LIPC—atherosclerosis	1.93e-05	0.000171	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.92e-05	0.000171	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—LEP—atherosclerosis	1.92e-05	0.00017	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—APOE—atherosclerosis	1.92e-05	0.00017	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOC3—atherosclerosis	1.91e-05	0.00017	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IGF1—atherosclerosis	1.91e-05	0.00017	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—LDLR—atherosclerosis	1.9e-05	0.000169	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CAV1—atherosclerosis	1.9e-05	0.000169	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—APOA1—atherosclerosis	1.9e-05	0.000169	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SERPINE1—atherosclerosis	1.88e-05	0.000167	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—atherosclerosis	1.88e-05	0.000167	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.88e-05	0.000167	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.88e-05	0.000167	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PDGFB—atherosclerosis	1.87e-05	0.000166	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CETP—atherosclerosis	1.86e-05	0.000165	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NOS3—atherosclerosis	1.85e-05	0.000164	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ESR1—atherosclerosis	1.83e-05	0.000163	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AGT—atherosclerosis	1.82e-05	0.000162	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SERPINE1—atherosclerosis	1.81e-05	0.000161	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—F2—atherosclerosis	1.81e-05	0.000161	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—FABP4—atherosclerosis	1.81e-05	0.000161	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LCAT—atherosclerosis	1.81e-05	0.000161	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CXCL8—atherosclerosis	1.81e-05	0.00016	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NOS3—atherosclerosis	1.8e-05	0.00016	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—APOE—atherosclerosis	1.79e-05	0.000158	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—LEP—atherosclerosis	1.79e-05	0.000158	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—SCARB1—atherosclerosis	1.78e-05	0.000158	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOA4—atherosclerosis	1.78e-05	0.000158	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CAV1—atherosclerosis	1.77e-05	0.000157	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—APOA1—atherosclerosis	1.76e-05	0.000157	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—AKT1—atherosclerosis	1.75e-05	0.000155	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.74e-05	0.000155	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CG—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NOS3—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—IL6—atherosclerosis	1.72e-05	0.000153	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ESR1—atherosclerosis	1.7e-05	0.000151	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—F2—atherosclerosis	1.68e-05	0.000149	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.68e-05	0.000149	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.66e-05	0.000148	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CXCL8—atherosclerosis	1.64e-05	0.000146	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—INS—atherosclerosis	1.64e-05	0.000146	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MMP9—atherosclerosis	1.63e-05	0.000145	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NFKB1—atherosclerosis	1.62e-05	0.000144	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCL2—atherosclerosis	1.61e-05	0.000143	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.61e-05	0.000143	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CG—atherosclerosis	1.61e-05	0.000143	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CXCL8—atherosclerosis	1.6e-05	0.000142	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MAPK8—atherosclerosis	1.59e-05	0.000141	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.59e-05	0.000141	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IGF1—atherosclerosis	1.59e-05	0.000141	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—AKT1—atherosclerosis	1.59e-05	0.000141	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—AKT1—atherosclerosis	1.58e-05	0.000141	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL6—atherosclerosis	1.56e-05	0.000139	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.55e-05	0.000137	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—MAPK3—atherosclerosis	1.54e-05	0.000137	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—AKT1—atherosclerosis	1.54e-05	0.000137	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CXCL8—atherosclerosis	1.54e-05	0.000136	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.53e-05	0.000136	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOA2—atherosclerosis	1.53e-05	0.000136	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.53e-05	0.000136	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.53e-05	0.000136	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—INS—atherosclerosis	1.52e-05	0.000135	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL6—atherosclerosis	1.52e-05	0.000135	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.51e-05	0.000134	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.51e-05	0.000134	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MAPK3—atherosclerosis	1.51e-05	0.000134	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SERPINE1—atherosclerosis	1.51e-05	0.000134	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCL2—atherosclerosis	1.5e-05	0.000133	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.5e-05	0.000133	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.48e-05	0.000132	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—AKT1—atherosclerosis	1.48e-05	0.000132	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MMP9—atherosclerosis	1.48e-05	0.000132	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IGF1—atherosclerosis	1.47e-05	0.000131	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NFKB1—atherosclerosis	1.47e-05	0.00013	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—atherosclerosis	1.47e-05	0.00013	CbGpPWpGaD
Aminophylline—HDAC2—Disease—STAT3—atherosclerosis	1.47e-05	0.00013	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL6—atherosclerosis	1.46e-05	0.00013	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LPA—atherosclerosis	1.46e-05	0.000129	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—STAT3—atherosclerosis	1.45e-05	0.000129	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MMP9—atherosclerosis	1.44e-05	0.000128	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MAPK8—atherosclerosis	1.44e-05	0.000128	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—AKT1—atherosclerosis	1.44e-05	0.000128	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NOS3—atherosclerosis	1.44e-05	0.000128	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NFKB1—atherosclerosis	1.43e-05	0.000127	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—BGN—atherosclerosis	1.41e-05	0.000125	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MAPK8—atherosclerosis	1.4e-05	0.000125	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.4e-05	0.000124	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SERPINE1—atherosclerosis	1.4e-05	0.000124	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—AKT1—atherosclerosis	1.4e-05	0.000124	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MAPK3—atherosclerosis	1.4e-05	0.000124	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOA5—atherosclerosis	1.4e-05	0.000124	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—FABP4—atherosclerosis	1.4e-05	0.000124	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LCAT—atherosclerosis	1.4e-05	0.000124	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MMP9—atherosclerosis	1.39e-05	0.000123	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MAPK3—atherosclerosis	1.39e-05	0.000123	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NFKB1—atherosclerosis	1.37e-05	0.000122	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOA4—atherosclerosis	1.37e-05	0.000122	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TGFB1—atherosclerosis	1.36e-05	0.000121	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.36e-05	0.000121	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MAPK8—atherosclerosis	1.35e-05	0.00012	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—AKT1—atherosclerosis	1.35e-05	0.00012	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TGFB1—atherosclerosis	1.35e-05	0.00012	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.35e-05	0.00012	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.35e-05	0.000119	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NOS3—atherosclerosis	1.34e-05	0.000119	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—atherosclerosis	1.33e-05	0.000118	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.33e-05	0.000118	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—STAT3—atherosclerosis	1.32e-05	0.000117	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.32e-05	0.000117	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.32e-05	0.000117	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.3e-05	0.000115	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—atherosclerosis	1.3e-05	0.000115	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.29e-05	0.000114	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—STAT3—atherosclerosis	1.28e-05	0.000114	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CXCL8—atherosclerosis	1.28e-05	0.000113	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MAPK3—atherosclerosis	1.26e-05	0.000112	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—atherosclerosis	1.25e-05	0.000111	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.24e-05	0.00011	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—STAT3—atherosclerosis	1.24e-05	0.00011	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOB—atherosclerosis	1.23e-05	0.000109	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MAPK3—atherosclerosis	1.23e-05	0.000109	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TGFB1—atherosclerosis	1.22e-05	0.000109	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.2e-05	0.000107	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.2e-05	0.000106	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TGFB1—atherosclerosis	1.19e-05	0.000106	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCL8—atherosclerosis	1.19e-05	0.000105	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MAPK3—atherosclerosis	1.18e-05	0.000105	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.18e-05	0.000105	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.18e-05	0.000105	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOA2—atherosclerosis	1.18e-05	0.000105	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.18e-05	0.000105	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—LPL—atherosclerosis	1.18e-05	0.000104	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.17e-05	0.000103	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.17e-05	0.000103	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.16e-05	0.000103	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LIPC—atherosclerosis	1.16e-05	0.000103	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MMP9—atherosclerosis	1.15e-05	0.000102	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOC3—atherosclerosis	1.15e-05	0.000102	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GPX1—atherosclerosis	1.15e-05	0.000102	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.15e-05	0.000102	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TGFB1—atherosclerosis	1.15e-05	0.000102	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LDLR—atherosclerosis	1.14e-05	0.000102	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NFKB1—atherosclerosis	1.14e-05	0.000101	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL6—atherosclerosis	1.13e-05	0.0001	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LPA—atherosclerosis	1.13e-05	9.99e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MAPK8—atherosclerosis	1.12e-05	9.97e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CETP—atherosclerosis	1.12e-05	9.92e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CD36—atherosclerosis	1.12e-05	9.92e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—BGN—atherosclerosis	1.09e-05	9.68e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOA5—atherosclerosis	1.08e-05	9.58e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MMP9—atherosclerosis	1.07e-05	9.53e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.07e-05	9.5e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NFKB1—atherosclerosis	1.06e-05	9.42e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.06e-05	9.4e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAPK8—atherosclerosis	1.04e-05	9.26e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.04e-05	9.25e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—AKT1—atherosclerosis	1.04e-05	9.24e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARA—atherosclerosis	1.04e-05	9.22e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.04e-05	9.22e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—atherosclerosis	1.04e-05	9.2e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—STAT3—atherosclerosis	1.03e-05	9.11e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—IL6—atherosclerosis	1.02e-05	9.09e-05	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—AKT1—atherosclerosis	1.02e-05	9.03e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL6—atherosclerosis	1.01e-05	9.01e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.01e-05	8.97e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AGT—atherosclerosis	1.01e-05	8.93e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALOX5—atherosclerosis	1e-05	8.9e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOE—atherosclerosis	9.86e-06	8.75e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MAPK3—atherosclerosis	9.8e-06	8.7e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CAV1—atherosclerosis	9.76e-06	8.67e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOA1—atherosclerosis	9.74e-06	8.65e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—atherosclerosis	9.63e-06	8.55e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—STAT3—atherosclerosis	9.54e-06	8.47e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TGFB1—atherosclerosis	9.51e-06	8.44e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—AKT1—atherosclerosis	9.44e-06	8.38e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—AKT1—atherosclerosis	9.36e-06	8.31e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL6—atherosclerosis	9.22e-06	8.18e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.12e-06	8.09e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAPK3—atherosclerosis	9.11e-06	8.09e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCA1—atherosclerosis	9.01e-06	8e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NAMPT—atherosclerosis	9e-06	7.99e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL6—atherosclerosis	8.97e-06	7.96e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LIPC—atherosclerosis	8.94e-06	7.94e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CG—atherosclerosis	8.89e-06	7.9e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOC3—atherosclerosis	8.88e-06	7.89e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TGFB1—atherosclerosis	8.84e-06	7.85e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LDLR—atherosclerosis	8.83e-06	7.84e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL6—atherosclerosis	8.63e-06	7.66e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CETP—atherosclerosis	8.62e-06	7.66e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARG—atherosclerosis	8.58e-06	7.62e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—AKT1—atherosclerosis	8.5e-06	7.55e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—INS—atherosclerosis	8.42e-06	7.48e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—AKT1—atherosclerosis	8.27e-06	7.34e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.26e-06	7.33e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—AKT1—atherosclerosis	7.96e-06	7.07e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.8e-06	6.92e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.73e-06	6.86e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALB—atherosclerosis	7.72e-06	6.85e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOB—atherosclerosis	7.4e-06	6.57e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NOS3—atherosclerosis	7.38e-06	6.56e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.2e-06	6.39e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL6—atherosclerosis	7.17e-06	6.36e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LPL—atherosclerosis	7.07e-06	6.28e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.95e-06	6.17e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GPX1—atherosclerosis	6.9e-06	6.12e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—atherosclerosis	6.75e-06	6e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CD36—atherosclerosis	6.72e-06	5.96e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL6—atherosclerosis	6.66e-06	5.92e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AKT1—atherosclerosis	6.61e-06	5.87e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.36e-06	5.65e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARA—atherosclerosis	6.24e-06	5.54e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AKT1—atherosclerosis	6.15e-06	5.46e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AGT—atherosclerosis	6.05e-06	5.37e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.96e-06	5.3e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOE—atherosclerosis	5.92e-06	5.26e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CAV1—atherosclerosis	5.87e-06	5.21e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOA1—atherosclerosis	5.86e-06	5.2e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOB—atherosclerosis	5.71e-06	5.07e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.56e-06	4.93e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LPL—atherosclerosis	5.46e-06	4.84e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.35e-06	4.75e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GPX1—atherosclerosis	5.32e-06	4.73e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CD36—atherosclerosis	5.18e-06	4.6e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARG—atherosclerosis	5.16e-06	4.58e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—INS—atherosclerosis	5.06e-06	4.49e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.91e-06	4.36e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARA—atherosclerosis	4.82e-06	4.28e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AGT—atherosclerosis	4.67e-06	4.14e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALB—atherosclerosis	4.64e-06	4.12e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOE—atherosclerosis	4.57e-06	4.06e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CAV1—atherosclerosis	4.53e-06	4.02e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOA1—atherosclerosis	4.52e-06	4.01e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NOS3—atherosclerosis	4.44e-06	3.94e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.13e-06	3.66e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.06e-06	3.6e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARG—atherosclerosis	3.98e-06	3.54e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—INS—atherosclerosis	3.91e-06	3.47e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALB—atherosclerosis	3.58e-06	3.18e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NOS3—atherosclerosis	3.43e-06	3.04e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AKT1—atherosclerosis	3.39e-06	3.01e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.13e-06	2.78e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AKT1—atherosclerosis	2.04e-06	1.81e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AKT1—atherosclerosis	1.57e-06	1.4e-05	CbGpPWpGaD
